While TP53 mutations can be quite heterogeneous, there are mutation hotspots at R175, R245, R248, R273, and R282 that are shared across multiple kinds of cancers, including hematologic cancers (99, 101). Here, TP53 is linked to hematopoietic and lymphoid cell neoplasm.